BioSpace News Archive

Rain Therapeutics Inc., a clinical-stage company developing precision oncology therapeutics, today announced a master program and a genomic analysis platform agreement for comprehensive genomic profiling tests utilizing artificial intelligence and precision medicine company Tempus’ genomic analysis platform.

Proceeds will support development of antibody drugs and discovery platform targeting pro-tumorigenic factors produced by fibroblasts in the tumor microenvironment, rendering resistant cancers treatable

Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has appointed Mardi Dier to its board of directors, Robin Knifsend as senior vice president of finance and operations and Antoni Ribas, M.D., Ph.D., to its scientific advisory board.

Walgreens Boots Alliance, Inc. will release its fiscal 2021 third quarter earnings results at 7 a.m. Eastern time Thursday, July 1, 2021 followed by a one-hour conference call with WBA management beginning at 8:30 a.m. Eastern time.

Guangzhou Bio-Gene, a clinical-stage biopharmaceutical company developing a pipeline of innovative oncology therapies, today announced the company will present at the 2021 American Society of Clinical Oncology (“ASCO”) Annual Meeting taking place June 4-8 th , 2021.

Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc.

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells directly within the patient’s body, announced today it will give a presentation at the 2021 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting , which is being held virtually from June 8-11, 2021.

Four years after the approval of the first CAR-T cell therapies, oncologists are referring more patients for treatment and becoming more comfortable with the cost

Marrone Bio Innovations, Inc . (NASDAQ: MBII) (MBI or “Marrone Bio”), an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, has entered into a partnership with ATP Nutrition of Manitoba, Canada to distribute Stargus Biofungicide on Canadian broad acre crops; primarily canola, dry beans, peas, soybeans and sunflower.

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Stifel 2021 Virtual Cross Sector Insight Conference.